Honz Pharmaceutical Co., Ltd.

¥4.83As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300086Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (8.26%)
Div yield —
ROE (22.20%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.38
PE TTM —
TSR TTM (44.74%)
Mkt cap ¥2.198B
ROIC (10.27%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥5.94
23.01%
(85.95%)
Hold 9|12|4|12|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.11
0.12
0.11
0.13
17.65%
24.49%
26.34%
24.92%
Revenue¥M
169.9
171.1
180.8
179.8
2.44%
5.26%
9.44%
7.78%
Peers (US$329.5M)
Cap (US$)
PE
332.8M
—
Capital
TTM
5Y
10Y
Leveragex
0.648
0.014
—
EBIT/Intx
0.488
0.899
0.880
Own earn%
(314.75)
23.99
28.77
Sh yield%
14.83
55.90
53.95
Owners
Insiders/Inst%
10.30
48.88
Short interest%
3.51
SBC / revenue%
3.71
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
3–10
$1 testx
0.3
Incr. ROIC%
0